The head of Russia's space agency said Monday that the Luna-25 spacecraft crashed into the moon after its engines failed to shut down correctly, and he blamed the country's decades-long pause in lunar exploration for the mishap.
The pilotless Luna-25 had been scheduled to land Monday while aiming to become the first spacecraft to touch down on the south pole of the moon, an area where scientists believe important reserves of frozen water and precious elements may exist.
Roscosmos Director General Yury Borisov said the spacecraft's engines were turned on over the weekend to put Luna-25 into a “pre-landing orbit" but did not shut down properly, plunging the lander onto the moon.
“Instead of the planned 84 seconds, it worked for 127 seconds. This was the main reason for the emergency,” Borisov told Russian state news channel Russia 24.
Roscosmos had contact with the spacecraft until 2:57 p.m. local time Saturday, when communication was lost and “the device passed into an open lunar orbit and crashed into the surface of the moon,” he said.
The lunar mission was Russia’s first since 1976, when it was part of the Soviet Union. Only three countries have managed successful moon landings: the Soviet Union, the United States and China.
“The negative experience of interrupting the lunar program for almost 50 years is the main reason for the failures,” Borisov said, adding “it would be the worst decision ever” for Russia to end the program now.
The Luna-25 was in a race with an Indian spacecraft launched on July 14 to be the first to reach the south pole. Both were expected to reach the moon between Aug. 21 and Aug. 23.
A previous Indian attempt to land at the moon's south pole in 2019 ended when the spacecraft crashed into the moon’s surface.
Luna-25 launched from the Vostochny Cosmodrome in Russia’s Far East on Aug. 10. The spaceport is a pet project of Russian President Vladimir Putin and key to his efforts to make Russia a space superpower.
Before the launch, Roscosmos said it wanted to show Russia “is a state capable of delivering a payload to the moon,” and “ensure Russia’s guaranteed access to the moon’s surface.”
Following the crash, the Russian space agency said the moon mission was about ensuring long-term “defense capability” as well as “technological sovereignty.”
“The race to develop the moon's natural resources has begun,” Borisov said Monday. “In the future, the moon will become an ideal platform for the exploration of deep space.”
Sanctions imposed on Russia since it launched a war in Ukraine nearly 18 months ago have affected its space program, making it more difficult to access Western technology.
The Luna-25 was initially meant to carry a small moon rover, but the idea was abandoned to reduce the weight of the craft for improved reliability, analysts said.
The lunar south pole is of particular interest to scientists, who believe the permanently shadowed polar craters may contain frozen water in the rocks that future explorers could transform into air and rocket fuel.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
